Exclusive

Publication

Byline

Location

Jaguar Health Plans To Adopt AI Platform For Crofelemer In Treating Intestinal Failure

India, April 14 -- Jaguar Health Inc. (JAGX), a commercial-stage pharmaceutical company, announced plans to use artificial intelligence (AI) platforms for the advancement of Crofelemer in treating int... Read More


Johnson & Johnson Q1 Earnings Slip Despite Revenue Growth; Lifts Midpoint Revenue Guidance

India, April 14 -- Johnson & Johnson (JNJ) reported first-quarter 2026 results on Tuesday, reflecting a decline in earnings despite 9.9% worldwide revenue growth. In addition, the firm raised its reve... Read More


Harmony Biosciences Appoints Glenn Reicin As CFO

India, April 14 -- Pharmaceutical company Harmony Biosciences Holdings, Inc. (HRMY) announced Tuesday the appointment of Glenn Reicin as Chief Financial Officer, effective immediately. Harmony is also... Read More


FDA Reminds 2200 Sponsors And Researchers To Disclose Trial Results

India, April 14 -- The U.S. Food and Drug Administration has reminded more than 2,200 medical product companies and researchers of the requirements to submit certain clinical trial results information... Read More


Wellgistics, Kare PharmTech Forms Joint Venture To Expand Patient Access

India, April 14 -- Shares of Wellgistics Health, Inc. (WGRX) are up by 25% after the company announced a new joint venture aimed at expanding access to more than 200,000 patient lives. Wellgistics He... Read More


Ligand Pharmaceuticals Stock Gains 7% After Partner Travere Receives FDA Approval For FILSPARI

India, April 14 -- Shares of Ligand Pharmaceuticals Incorporated (LGND) are moving up about 7 percent on Tuesday morning trading after its partner Travere Therapeutics, Inc. received approval from the... Read More


Travere Therapeutics Stock Surges 31% On FDA Approval Of FILSPARI

India, April 14 -- Travere Therapeutics, Inc. (TVTX) shares jumped 31.57 percent to $40.42, gaining $9.72 on Monday, after the company received U.S. Food and Drug Administration approval for FILSPARI ... Read More


Virax CEO Foster Releases Shareholder Letter Regarding Upcoming Milestones

India, April 14 -- Virax Biolabs Group Limited (VRAX), a biotechnology company, released today a shareholder letter by Chief Executive Officer James Foster, providing updates on strategic priorities a... Read More


Clearmind's CMND-100 Hits Primary Endpoint In Alcohol Use Disorder; Stock Down

India, April 14 -- Clearmind Medicine Inc. (CMND) has announced that CMND-100 has met the primary endpoint in its FDA-approved Phase I/IIa clinical trial for Alcohol Use Disorder, marking a key milest... Read More


Sanyo Shokai Ltd Bottom Line Advances In Full Year

India, April 14 -- Sanyo Shokai Ltd (8011.T) revealed a profit for its full year that Increased, from the same period last year The company's earnings totaled JPY4.113 billion, or JPY392.17 per share... Read More